Top Stock Movers Now: StubHub, DoorDash, Netflix, and More

U.S. equities closed mixed on Friday, with the S&P 500 gaining 0.5% and Nasdaq 0.8% while the Dow declined 0.3%, following a prior day's tech selloff. Significant stock movements included StubHub's nearly 25% plunge after declining guidance, Bristol-Myers Squibb's 3.4% drop due to a halted drug trial, and Netflix's 3% slip amid Warner Bros. Discovery acquisition reports. Conversely, Cidara Therapeutics more than doubled on news of a $9.2 billion acquisition by Merck at $221.50 per share, and DoorDash rose almost 7%. In commodities, Bitcoin fell below $95,000, while oil futures climbed 2.5% to over $60/barrel.

Analysis

The broader U.S. equities market exhibited a mixed performance on Friday, with the S&P 500 gaining 0.5% and the Nasdaq 0.8%, partially recovering from a prior tech selloff, while the Dow Jones Industrial Average declined 0.3%. Individual stock movements were significant, with StubHub (STUB) plummeting nearly 25% after withholding quarterly guidance, marking its worst day since IPO. Conversely, DoorDash (DASH) rose almost 7%, reclaiming some recent losses following its earnings report.

Bristol-Myers Squibb (BMY) shares fell 3.4% following the halt of a co-developed heart drug trial with Johnson & Johnson (JNJ), impacting the healthcare sector. In M&A news, Cidara Therapeutics (CDTX) more than doubled in value, soaring over 100%, after Merck (MRK) announced a $9.2 billion acquisition at $221.50 per share, highlighting significant premium potential in biotech. Netflix (NFLX) also slipped 3% amid reports of a potential bid for Warner Bros. Discovery (WBD).

Commodity markets showed divergence, with oil futures climbing 2.5% to above $60 per barrel, while gold futures decreased by approximately 2%. The cryptocurrency market experienced a downturn, as Bitcoin briefly dropped below $95,000, alongside declines in most other major cryptocurrencies. The 10-year Treasury yield remained largely unchanged, and the U.S. dollar weakened slightly against major currencies.

Key Decisions for Investors

• Investors should closely monitor companies that withhold guidance, as seen with StubHub, for potential downside risk and operational uncertainty.
• Evaluate M&A activity in the biotech sector, exemplified by the Cidara/Merck deal, for significant premium opportunities and strategic shifts.
• Assess the impact of clinical trial halts on pharmaceutical holdings, considering the BMY/JNJ situation, and remain cognizant of cryptocurrency market volatility as a potential indicator for broader risk sentiment.